Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma
Alexandre Reuben, Zachary A Cooper, Rodabe N Amaria, Marie A Forget, Cara Haymaker, Chantale Bernatchez, Pei-ling Chen, Michael T Tetzlaff, Lynda Chin, Karen C Dwyer, Jennifer A Wargo
Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P200; DOI: 10.1186/2051-1426-2-S3-P200